Genelux (GNLX) Stock: Buy, Sell, or Hold?
$1.90
+0.02 (+1.06%)
â˛
5d:
+4.4%
30d:
-18.1%
90d:
-30.66%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
47/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.96 â $2.47
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.5x
Next 12M consensus est.
Wall Street Target
$18.83
+891.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.77 / $2.18
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GNLX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GNLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GNLX is currently trading at $1.90, which is considered slightly low relative to its 30-day fair value range of $1.96 to $2.47.
Technical Outlook: Technically, GNLX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $2.18.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.83 (+891.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNLX is in a strong downtrend. Immediate support is located at $1.77, while resistance sits at $2.18.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.83 (+891.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.96 -
$2.47
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.96 -
$2.47
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.77
Resistance Level
$2.18
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 891.2% below Wall St target ($18.83)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.53
Wall Street Target
$18.83
(+891.2%)
Revenue Growth (YoY)
-95.3%
Share GNLX Analysis
Share this live GNLX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GNLX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $GNLX with a potential price breakout towards $2.22.
Key Retail Themes:
Price Breakout
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:38 AM ET
Data refreshes hourly during market hours. Next update: 5:38 AM
Data refreshes hourly during market hours. Next update: 5:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American DeposâĻ |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GNLX Research Pages
